{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:15:12Z","timestamp":1793924112657,"version":"4.8.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s11926-020-00978-5","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T16:03:09Z","timestamp":1611936189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["T Cell Abnormalities in the Pathogenesis of Systemic Lupus Erythematosus: an Update"],"prefix":"10.1007","volume":"23","author":[{"given":"Ping-Min","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George C.","family":"Tsokos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"issue":"3","key":"978_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrrheum.2013.184","volume":"10","author":"NJ Olsen","year":"2014","unstructured":"Olsen NJ, Karp DR. Autoantibodies and SLE: the threshold for disease. Nat Rev Rheumatol. 2014;10(3):181\u20136. https:\/\/doi.org\/10.1038\/nrrheum.2013.184.","journal-title":"Nat Rev Rheumatol"},{"issue":"22","key":"978_CR2","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365(22):2110\u201321. https:\/\/doi.org\/10.1056\/NEJMra1100359.","journal-title":"N Engl J Med"},{"issue":"6","key":"978_CR3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","volume":"21","author":"GC Tsokos","year":"2020","unstructured":"Tsokos GC. Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol. 2020;21(6):605\u201314. https:\/\/doi.org\/10.1038\/s41590-020-0677-6.","journal-title":"Nat Immunol"},{"key":"978_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2019.06.005","volume":"61","author":"A Seth","year":"2019","unstructured":"Seth A, Craft J. Spatial and functional heterogeneity of follicular helper T cells in autoimmunity. Curr Opin Immunol. 2019;61:1\u20139. https:\/\/doi.org\/10.1016\/j.coi.2019.06.005.","journal-title":"Curr Opin Immunol"},{"issue":"10","key":"978_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1089\/jir.2011.0029","volume":"31","author":"SA Apostolidis","year":"2011","unstructured":"Apostolidis SA, Lieberman LA, Kis-Toth K, Crisp\u00edn JC, Tsokos GC. The dysregulation of cytokine networks in systemic lupus erythematosus. J Interf Cytokine Res. 2011;31(10):769\u201379. https:\/\/doi.org\/10.1089\/jir.2011.0029.","journal-title":"J Interf Cytokine Res"},{"issue":"26","key":"978_CR6","doi-asserted-by":"publisher","first-page":"9258","DOI":"10.1073\/pnas.0500132102","volume":"102","author":"U Wellmann","year":"2005","unstructured":"Wellmann U, Letz M, Herrmann M, Angerm\u00fcller S, Kalden JR, Winkler TH. The evolution of human anti-double-stranded DNA autoantibodies. Proc Natl Acad Sci U S A. 2005;102(26):9258\u201363. https:\/\/doi.org\/10.1073\/pnas.0500132102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"978_CR7","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1084\/jem.20092712","volume":"207","author":"W Guo","year":"2010","unstructured":"Guo W, Smith D, Aviszus K, Detanico T, Heiser RA, Wysocki LJ. Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity. J Exp Med. 2010;207(10):2225\u201337. https:\/\/doi.org\/10.1084\/jem.20092712.","journal-title":"J Exp Med"},{"issue":"12","key":"978_CR8","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.4049\/jimmunol.152.12.6011","volume":"152","author":"ES Sobel","year":"1994","unstructured":"Sobel ES, Kakkanaiah VN, Kakkanaiah M, Cheek RL, Cohen PL, Eisenberg RA. T-B collaboration for autoantibody production in lpr mice is cognate and MHC-restricted. J Immunol. 1994;152(12):6011\u20136.","journal-title":"J Immunol"},{"issue":"2","key":"978_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1084\/jem.20091777","volume":"207","author":"D Zotos","year":"2010","unstructured":"Zotos D, Coquet JM, Zhang Y, Light A, D'Costa K, Kallies A, et al. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J Exp Med. 2010;207(2):365\u201378. https:\/\/doi.org\/10.1084\/jem.20091777.","journal-title":"J Exp Med"},{"issue":"7214","key":"978_CR10","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nature07345","volume":"455","author":"H Qi","year":"2008","unstructured":"Qi H, Cannons JL, Klauschen F, Schwartzberg PL, Germain RN. SAP-controlled T-B cell interactions underlie germinal Centre formation. Nature. 2008;455(7214):764\u20139. https:\/\/doi.org\/10.1038\/nature07345.","journal-title":"Nature."},{"issue":"6","key":"978_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/s1074-7613(00)80578-6","volume":"8","author":"TD Randall","year":"1998","unstructured":"Randall TD, Heath AW, Santos-Argumedo L, Howard MC, Weissman IL, Lund FE. Arrest of B lymphocyte terminal differentiation by CD40 signaling: mechanism for lack of antibody-secreting cells in germinal centers. Immunity. 1998;8(6):733\u201342. https:\/\/doi.org\/10.1016\/s1074-7613(00)80578-6.","journal-title":"Immunity."},{"issue":"7533","key":"978_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature13803","volume":"517","author":"D Liu","year":"2015","unstructured":"Liu D, Xu H, Shih C, Wan Z, Ma X, Ma W, et al. T-B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction. Nature. 2015;517(7533):214\u20138. https:\/\/doi.org\/10.1038\/nature13803.","journal-title":"Nature."},{"issue":"7041","key":"978_CR13","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature03555","volume":"435","author":"CG Vinuesa","year":"2005","unstructured":"Vinuesa CG, Cook MC, Angelucci C, Athanasopoulos V, Rui L, Hill KM, et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature. 2005;435(7041):452\u20138. https:\/\/doi.org\/10.1038\/nature03555.","journal-title":"Nature."},{"issue":"3","key":"978_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1084\/jem.20081886","volume":"206","author":"MA Linterman","year":"2009","unstructured":"Linterman MA, Rigby RJ, Wong RK, Yu D, Brink R, Cannons JL, et al. Follicular helper T cells are required for systemic autoimmunity. J Exp Med. 2009;206(3):561\u201376. https:\/\/doi.org\/10.1084\/jem.20081886.","journal-title":"J Exp Med"},{"issue":"6","key":"978_CR15","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.4049\/jimmunol.171.6.2848","volume":"171","author":"H Iwai","year":"2003","unstructured":"Iwai H, Abe M, Hirose S, Tsushima F, Tezuka K, Akiba H, et al. Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis. J Immunol. 2003;171(6):2848\u201354. https:\/\/doi.org\/10.4049\/jimmunol.171.6.2848.","journal-title":"J Immunol"},{"issue":"5","key":"978_CR16","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.4049\/jimmunol.160.5.2158","volume":"160","author":"SL Kalled","year":"1998","unstructured":"Kalled SL, Cutler AH, Datta SK, Thomas DW. Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function. J Immunol. 1998;160(5):2158\u201365.","journal-title":"J Immunol"},{"issue":"5","key":"978_CR17","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1073\/pnas.0807309106","volume":"106","author":"JA Bubier","year":"2009","unstructured":"Bubier JA, Sproule TJ, Foreman O, Spolski R, Shaffer DJ, Morse HC 3rd, et al. A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice. Proc Natl Acad Sci U S A. 2009;106(5):1518\u201323. https:\/\/doi.org\/10.1073\/pnas.0807309106.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"978_CR18","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.4049\/jimmunol.1601687","volume":"198","author":"JY Choi","year":"2017","unstructured":"Choi JY, Seth A, Kashgarian M, Terrillon S, Fung E, Huang L, et al. Disruption of pathogenic cellular networks by IL-21 blockade leads to disease amelioration in murine lupus. J Immunol. 2017;198(7):2578\u201388. https:\/\/doi.org\/10.4049\/jimmunol.1601687.","journal-title":"J Immunol"},{"issue":"5589","key":"978_CR19","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1126\/science.1073924","volume":"297","author":"J William","year":"2002","unstructured":"William J, Euler C, Christensen S, Shlomchik MJ. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science (New York, NY). 2002;297(5589):2066\u201370. https:\/\/doi.org\/10.1126\/science.1073924.","journal-title":"Science (New York, NY)"},{"issue":"12","key":"978_CR20","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1084\/jem.20080840","volume":"205","author":"JM Odegard","year":"2008","unstructured":"Odegard JM, Marks BR, DiPlacido LD, Poholek AC, Kono DH, Dong C, et al. ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J Exp Med. 2008;205(12):2873\u201386. https:\/\/doi.org\/10.1084\/jem.20080840.","journal-title":"J Exp Med"},{"issue":"7","key":"978_CR21","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1084\/jem.20102065","volume":"208","author":"SK Lee","year":"2011","unstructured":"Lee SK, Rigby RJ, Zotos D, Tsai LM, Kawamoto S, Marshall JL, et al. B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells. J Exp Med. 2011;208(7):1377\u201388. https:\/\/doi.org\/10.1084\/jem.20102065.","journal-title":"J Exp Med"},{"issue":"1","key":"978_CR22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","volume":"34","author":"R Morita","year":"2011","unstructured":"Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity. 2011;34(1):108\u201321. https:\/\/doi.org\/10.1016\/j.immuni.2010.12.012.","journal-title":"Immunity."},{"issue":"4","key":"978_CR23","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/art.39020","volume":"67","author":"JY Choi","year":"2015","unstructured":"Choi JY, Ho JH, Pasoto SG, Bunin V, Kim ST, Carrasco S, et al. Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. Arthritis Rheumatol (Hoboken, NJ). 2015;67(4):988\u201399. https:\/\/doi.org\/10.1002\/art.39020.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"9","key":"978_CR24","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1177\/0961203314567750","volume":"24","author":"X Zhang","year":"2015","unstructured":"Zhang X, Lindwall E, Gauthier C, Lyman J, Spencer N, Alarakhia A, et al. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production. Lupus. 2015;24(9):909\u201317. https:\/\/doi.org\/10.1177\/0961203314567750.","journal-title":"Lupus."},{"issue":"230","key":"978_CR25","doi-asserted-by":"publisher","first-page":"230ra46","DOI":"10.1126\/scitranslmed.3008146","volume":"6","author":"VM Liarski","year":"2014","unstructured":"Liarski VM, Kaverina N, Chang A, Brandt D, Yanez D, Talasnik L, et al. Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue. Sci Transl Med. 2014;6(230):230ra46. https:\/\/doi.org\/10.1126\/scitranslmed.3008146.","journal-title":"Sci Transl Med"},{"issue":"7639","key":"978_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature20810","volume":"542","author":"DA Rao","year":"2017","unstructured":"\u2022 Rao DA, Gurish MF, Marshall JL, Slowikowski K, Fonseka CY, Liu Y, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542(7639):110\u20134. https:\/\/doi.org\/10.1038\/nature20810This study is the first to demonstrate peripheral T helper, and its potential role in driving B cell maturation in the inflamed tissue.","journal-title":"Nature"},{"key":"978_CR27","doi-asserted-by":"publisher","unstructured":"Bocharnikov AV, Keegan J, Wacleche VS, Cao Y, Fonseka CY, Wang G, et al. PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21. JCI insight. 2019;4(20). https:\/\/doi.org\/10.1172\/jci.insight.130062.","DOI":"10.1172\/jci.insight.130062"},{"issue":"7","key":"978_CR28","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","volume":"20","author":"A Arazi","year":"2019","unstructured":"\u2022 Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, et al. The immune cell landscape in kidneys of patients with lupus nephritis. Nat Immunol. 2019;20(7):902\u201314. https:\/\/doi.org\/10.1038\/s41590-019-0398-xA well-constructed cohort of single-cell RNA-seq of immune cells from patients with lupus nephritis.","journal-title":"Nat Immunol"},{"issue":"2","key":"978_CR29","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1681\/asn.2010050515","volume":"22","author":"M Espeli","year":"2011","unstructured":"Espeli M, Bokers S, Giannico G, Dickinson HA, Bardsley V, Fogo AB, et al. Local renal autoantibody production in lupus nephritis. J Am Soc Nephrol. 2011;22(2):296\u2013305. https:\/\/doi.org\/10.1681\/asn.2010050515.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"978_CR30","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/art.40038","volume":"69","author":"D Comte","year":"2017","unstructured":"Comte D, Karampetsou MP, Yoshida N, Kis-Toth K, Kyttaris VC, Tsokos GC. Signaling lymphocytic activation molecule family member 7 engagement restores defective effector CD8+ T cell function in systemic lupus erythematosus. Arthritis Rheumatol (Hoboken, NJ). 2017;69(5):1035\u201344. https:\/\/doi.org\/10.1002\/art.40038.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"4","key":"978_CR31","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/art.1780380408","volume":"38","author":"W Stohl","year":"1995","unstructured":"Stohl W. Impaired polyclonal T cell cytolytic activity. A possible risk factor for systemic lupus erythematosus. Arthritis Rheum. 1995;38(4):506\u201316. https:\/\/doi.org\/10.1002\/art.1780380408.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"978_CR32","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4049\/jimmunol.160.2.652","volume":"160","author":"SL Peng","year":"1998","unstructured":"Peng SL, Moslehi J, Robert ME, Craft J. Perforin protects against autoimmunity in lupus-prone mice. J Immunol. 1998;160(2):652\u201360.","journal-title":"J Immunol"},{"issue":"6","key":"978_CR33","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4049\/jimmunol.139.6.1840","volume":"139","author":"CS Via","year":"1987","unstructured":"Via CS, Sharrow SO, Shearer GM. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. J Immunol. 1987;139(6):1840\u20139.","journal-title":"J Immunol"},{"issue":"2","key":"978_CR34","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.4049\/jimmunol.172.2.1287","volume":"172","author":"I Kang","year":"2004","unstructured":"Kang I, Quan T, Nolasco H, Park SH, Hong MS, Crouch J, et al. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol. 2004;172(2):1287\u201394. https:\/\/doi.org\/10.4049\/jimmunol.172.2.1287.","journal-title":"J Immunol"},{"issue":"10","key":"978_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002328","volume":"7","author":"M Larsen","year":"2011","unstructured":"Larsen M, Sauce D, Deback C, Arnaud L, Mathian A, Miyara M, et al. Exhausted cytotoxic control of Epstein-Barr virus in human lupus. PLoS Pathog. 2011;7(10):e1002328. https:\/\/doi.org\/10.1371\/journal.ppat.1002328.","journal-title":"PLoS Pathog"},{"issue":"12","key":"978_CR36","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","volume":"12","author":"GC Tsokos","year":"2016","unstructured":"Tsokos GC, Lo MS, Costa Reis P, Sullivan KE. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016;12(12):716\u201330. https:\/\/doi.org\/10.1038\/nrrheum.2016.186.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"978_CR37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/art.39410","volume":"68","author":"K Kis-Toth","year":"2016","unstructured":"Kis-Toth K, Comte D, Karampetsou MP, Kyttaris VC, Kannan L, Terhorst C, et al. Selective loss of signaling lymphocytic activation molecule family member 4-positive CD8+ T cells contributes to the decreased cytotoxic cell activity in systemic lupus erythematosus. Arthritis Rheumatol (Hoboken, NJ). 2016;68(1):164\u201373. https:\/\/doi.org\/10.1002\/art.39410.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"1","key":"978_CR38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.celrep.2019.12.014","volume":"30","author":"E Katsuyama","year":"2020","unstructured":"\u2022 Katsuyama E, Suarez-Fueyo A, Bradley SJ, Mizui M, Marin AV, Mulki L, et al. The CD38\/NAD\/SIRTUIN1\/EZH2 axis mitigates cytotoxic CD8 T cell function and identifies patients with SLE prone to infections. Cell Rep. 2020;30(1):112\u201323.e4. https:\/\/doi.org\/10.1016\/j.celrep.2019.12.014This study nicely links CD38 with CD8+ T cell exhaustion and risk of infection in lupus patients.","journal-title":"Cell Rep"},{"issue":"12","key":"978_CR39","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1056\/NEJMoa2023325","volume":"383","author":"L Ostendorf","year":"2020","unstructured":"Ostendorf L, Burns M, Durek P, Heinz GA, Heinrich F, Garantziotis P, et al. Targeting CD38 with daratumumab in refractory systemic lupus erythematosus. N Engl J Med. 2020;383(12):1149\u201355. https:\/\/doi.org\/10.1056\/NEJMoa2023325.","journal-title":"N Engl J Med"},{"issue":"11","key":"978_CR40","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1172\/jci120859","volume":"128","author":"JS Tilstra","year":"2018","unstructured":"Tilstra JS, Avery L, Menk AV, Gordon RA, Smita S, Kane LP, et al. Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted. J Clin Invest. 2018;128(11):4884\u201397. https:\/\/doi.org\/10.1172\/jci120859.","journal-title":"J Clin Invest"},{"issue":"8","key":"978_CR41","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/art.10461","volume":"46","author":"FA Houssiau","year":"2002","unstructured":"Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido EER, Danieli MG, et al. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum. 2002;46(8):2121\u201331. https:\/\/doi.org\/10.1002\/art.10461.","journal-title":"Arthritis Rheum"},{"key":"978_CR42","doi-asserted-by":"publisher","unstructured":"\u2022 Chen PM, Wilson PC, Shyer JA, Veselits M, Steach HR, Cui C et al. Kidney tissue hypoxia dictates T cell-mediated injury in murine lupus nephritis. Sci Transl Med. 2020;12(538). doi:https:\/\/doi.org\/10.1126\/scitranslmed.aay1620. This is the first study to discuss how inflammatory microenvironment can affect T cell phenotype in promoting tissue damage, and this maladaptation can be intervened to reverse organ damage.","DOI":"10.1126\/scitranslmed.aay1620"},{"issue":"6","key":"978_CR43","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1172\/jci69073","volume":"124","author":"PP Kapitsinou","year":"2014","unstructured":"Kapitsinou PP, Sano H, Michael M, Kobayashi H, Davidoff O, Bian A, et al. Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury. J Clin Invest. 2014;124(6):2396\u2013409. https:\/\/doi.org\/10.1172\/jci69073.","journal-title":"J Clin Invest"},{"issue":"7","key":"978_CR44","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1002\/art.22654","volume":"56","author":"L Couzi","year":"2007","unstructured":"Couzi L, Merville P, Deminiere C, Moreau JF, Combe C, Pellegrin JL, et al. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis. Arthritis Rheum. 2007;56(7):2362\u201370. https:\/\/doi.org\/10.1002\/art.22654.","journal-title":"Arthritis Rheum"},{"key":"978_CR45","doi-asserted-by":"publisher","first-page":"102424","DOI":"10.1016\/j.jaut.2020.102424","volume":"109","author":"M Zhou","year":"2020","unstructured":"Zhou M, Guo C, Li X, Huang Y, Li M, Zhang T, et al. JAK\/STAT signaling controls the fate of CD8(+)CD103(+) tissue-resident memory T cell in lupus nephritis. J Autoimmun. 2020;109:102424. https:\/\/doi.org\/10.1016\/j.jaut.2020.102424.","journal-title":"J Autoimmun"},{"issue":"11","key":"978_CR46","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1681\/ASN.V11112044","volume":"11","author":"AM Woltman","year":"2000","unstructured":"Woltman AM, de Haij S, Boonstra JG, Gobin SJ, Daha MR, van Kooten C. Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J Am Soc Nephrol. 2000;11(11):2044\u201355.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"978_CR47","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1172\/jci73411","volume":"124","author":"T Koga","year":"2014","unstructured":"Koga T, Hedrich CM, Mizui M, Yoshida N, Otomo K, Lieberman LA, et al. CaMK4-dependent activation of AKT\/mTOR and CREM-\u03b1 underlies autoimmunity-associated Th17 imbalance. J Clin Invest. 2014;124(5):2234\u201345. https:\/\/doi.org\/10.1172\/jci73411.","journal-title":"J Clin Invest"},{"issue":"12","key":"978_CR48","doi-asserted-by":"publisher","first-page":"5533","DOI":"10.4049\/jimmunol.1501603","volume":"195","author":"K Otomo","year":"2015","unstructured":"Otomo K, Koga T, Mizui M, Yoshida N, Kriegel C, Bickerton S, et al. Cutting edge: nanogel-based delivery of an inhibitor of CaMK4 to CD4+ T cells suppresses experimental autoimmune encephalomyelitis and lupus-like disease in mice. J Immunol. 2015;195(12):5533\u20137. https:\/\/doi.org\/10.4049\/jimmunol.1501603.","journal-title":"J Immunol"},{"issue":"7","key":"978_CR49","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.4049\/jimmunol.1201785","volume":"189","author":"T Koga","year":"2012","unstructured":"Koga T, Ichinose K, Mizui M, Crisp\u00edn JC, Tsokos GC. Calcium\/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupus. J Immunol. 2012;189(7):3490\u20136. https:\/\/doi.org\/10.4049\/jimmunol.1201785.","journal-title":"J Immunol"},{"issue":"9","key":"978_CR50","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1002\/eji.201445219","volume":"45","author":"Y Liu","year":"2015","unstructured":"Liu Y, Liao J, Zhao M, Wu H, Yung S, Chan TM, et al. Increased expression of TLR2 in CD4(+) T cells from SLE patients enhances immune reactivity and promotes IL-17 expression through histone modifications. Eur J Immunol. 2015;45(9):2683\u201393. https:\/\/doi.org\/10.1002\/eji.201445219.","journal-title":"Eur J Immunol"},{"issue":"37","key":"978_CR51","doi-asserted-by":"publisher","first-page":"26775","DOI":"10.1074\/jbc.M113.483743","volume":"288","author":"SA Apostolidis","year":"2013","unstructured":"Apostolidis SA, Rauen T, Hedrich CM, Tsokos GC, Crisp\u00edn JC. Protein phosphatase 2A enables expression of interleukin 17 (IL-17) through chromatin remodeling. J Biol Chem. 2013;288(37):26775\u201384. https:\/\/doi.org\/10.1074\/jbc.M113.483743.","journal-title":"J Biol Chem"},{"issue":"30","key":"978_CR52","doi-asserted-by":"publisher","first-page":"21936","DOI":"10.1074\/jbc.M113.467266","volume":"288","author":"K Sunahori","year":"2013","unstructured":"Sunahori K, Nagpal K, Hedrich CM, Mizui M, Fitzgerald LM, Tsokos GC. The catalytic subunit of protein phosphatase 2A (PP2Ac) promotes DNA hypomethylation by suppressing the phosphorylated mitogen-activated protein kinase\/extracellular signal-regulated kinase (ERK) kinase (MEK)\/phosphorylated ERK\/DNMT1 protein pathway in T-cells from controls and systemic lupus erythematosus patients. J Biol Chem. 2013;288(30):21936\u201344. https:\/\/doi.org\/10.1074\/jbc.M113.467266.","journal-title":"J Biol Chem"},{"key":"978_CR53","doi-asserted-by":"publisher","unstructured":"\u2022 Choi SC, Brown J, Gong M, Ge Y, Zadeh M, Li W, et al. Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice. Sci Transl Med. 2020;12(551). https:\/\/doi.org\/10.1126\/scitranslmed.aax2220A very nice illustration of how microbiota and altered metabolism contribute to lupus pathogenesis.","DOI":"10.1126\/scitranslmed.aax2220"},{"issue":"5","key":"978_CR54","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/BOR.0b013e32833c62b0","volume":"22","author":"JC Crispin","year":"2010","unstructured":"Crispin JC, Tsokos GC. Interleukin-17-producing T cells in lupus. Curr Opin Rheumatol. 2010;22(5):499\u2013503. https:\/\/doi.org\/10.1097\/BOR.0b013e32833c62b0.","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"978_CR55","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1002\/art.39268","volume":"67","author":"XJ Zhou","year":"2015","unstructured":"Zhou XJ, Mu R, Li C, Nath SK, Zhang YM, Qi YY, et al. Association of variants in CCR6 with susceptibility to lupus nephritis in Chinese. Arthritis Rheumatol (Hoboken, NJ). 2015;67(11):3091\u20133. https:\/\/doi.org\/10.1002\/art.39268.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"1","key":"978_CR56","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.immuni.2016.06.028","volume":"45","author":"A Poissonnier","year":"2016","unstructured":"Poissonnier A, Sanseau D, Le Gallo M, Malleter M, Levoin N, Viel R, et al. CD95-mediated calcium signaling promotes T helper 17 trafficking to inflamed organs in lupus-prone mice. Immunity. 2016;45(1):209\u201323. https:\/\/doi.org\/10.1016\/j.immuni.2016.06.028.","journal-title":"Immunity."},{"key":"978_CR57","doi-asserted-by":"publisher","unstructured":"Krebs CF, Reimers D, Zhao Y, Paust HJ, Bartsch P, Nu\u00f1ez S, et al. Pathogen-induced tissue-resident memory T(H)17 (T(RM)17) cells amplify autoimmune kidney disease. Sci Immunol. 2020;5(50). https:\/\/doi.org\/10.1126\/sciimmunol.aba4163.","DOI":"10.1126\/sciimmunol.aba4163"},{"issue":"12","key":"978_CR58","doi-asserted-by":"publisher","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","volume":"181","author":"JC Crispin","year":"2008","unstructured":"Crispin JC, Oukka M, Bayliss G, Cohen RA, Van Beek CA, Stillman IE, et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol. 2008;181(12):8761\u20136. https:\/\/doi.org\/10.4049\/jimmunol.181.12.8761.","journal-title":"J Immunol"},{"issue":"5","key":"978_CR59","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.4049\/jimmunol.1301005","volume":"191","author":"ZW Lai","year":"2013","unstructured":"Lai ZW, Borsuk R, Shadakshari A, Yu J, Dawood M, Garcia R, et al. Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus. J Immunol. 2013;191(5):2236\u201346. https:\/\/doi.org\/10.4049\/jimmunol.1301005.","journal-title":"J Immunol"},{"issue":"44","key":"978_CR60","doi-asserted-by":"publisher","first-page":"31880","DOI":"10.1074\/jbc.M113.508655","volume":"288","author":"CM Hedrich","year":"2013","unstructured":"Hedrich CM, Rauen T, Crispin JC, Koga T, Ioannidis C, Zajdel M, et al. cAMP-responsive element modulator \u03b1 (CREM\u03b1) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8- T cells in health and disease. J Biol Chem. 2013;288(44):31880\u20137. https:\/\/doi.org\/10.1074\/jbc.M113.508655.","journal-title":"J Biol Chem"},{"issue":"6","key":"978_CR61","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/eji.201546056","volume":"46","author":"N Rodr\u00edguez-Rodr\u00edguez","year":"2016","unstructured":"Rodr\u00edguez-Rodr\u00edguez N, Apostolidis SA, Fitzgerald L, Meehan BS, Corbett AJ, Mart\u00edn-Villa JM, et al. Pro-inflammatory self-reactive T cells are found within murine TCR-\u03b1\u03b2(+) CD4(\u2212) CD8(\u2212) PD-1(+) cells. Eur J Immunol. 2016;46(6):1383\u201391. https:\/\/doi.org\/10.1002\/eji.201546056.","journal-title":"Eur J Immunol"},{"issue":"2","key":"978_CR62","doi-asserted-by":"publisher","first-page":"540","DOI":"10.4049\/jimmunol.1400931","volume":"193","author":"G Amarilyo","year":"2014","unstructured":"Amarilyo G, Lourenco EV, Shi FD, La Cava A. IL-17 promotes murine lupus. J Immunol. 2014;193(2):540\u20133. https:\/\/doi.org\/10.4049\/jimmunol.1400931.","journal-title":"J Immunol"},{"issue":"2","key":"978_CR63","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/art.38955","volume":"67","author":"T Schmidt","year":"2015","unstructured":"Schmidt T, Paust HJ, Krebs CF, Turner JE, Kaffke A, Bennstein SB, et al. Function of the Th17\/interleukin-17A immune response in murine lupus nephritis. Arthritis Rheumatol (Hoboken, NJ). 2015;67(2):475\u201387. https:\/\/doi.org\/10.1002\/art.38955.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"8","key":"978_CR64","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1002\/1529-0131(199908)42:8<1644::aid-anr12>3.0.co;2-l","volume":"42","author":"M Akahoshi","year":"1999","unstructured":"Akahoshi M, Nakashima H, Tanaka Y, Kohsaka T, Nagano S, Ohgami E, et al. Th1\/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum. 1999;42(8):1644\u20138. https:\/\/doi.org\/10.1002\/1529-0131(199908)42:8<1644::aid-anr12>3.0.co;2-l.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"978_CR65","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/ki.2012.242","volume":"82","author":"A Okamoto","year":"2012","unstructured":"Okamoto A, Fujio K, Tsuno NH, Takahashi K, Yamamoto K. Kidney-infiltrating CD4+ T-cell clones promote nephritis in lupus-prone mice. Kidney Int. 2012;82(9):969\u201379. https:\/\/doi.org\/10.1038\/ki.2012.242.","journal-title":"Kidney Int"},{"issue":"1","key":"978_CR66","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4049\/jimmunol.161.1.494","volume":"161","author":"A Schwarting","year":"1998","unstructured":"Schwarting A, Wada T, Kinoshita K, Tesch G, Kelley VR. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. J Immunol. 1998;161(1):494\u2013503.","journal-title":"J Immunol"},{"issue":"7","key":"978_CR67","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.4049\/jimmunol.170.7.3915","volume":"170","author":"E Kikawada","year":"2003","unstructured":"Kikawada E, Lenda DM, Kelley VR. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology. J Immunol. 2003;170(7):3915\u201325.","journal-title":"J Immunol"},{"issue":"1","key":"978_CR68","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/art.24136","volume":"60","author":"P Enghard","year":"2009","unstructured":"Enghard P, Humrich JY, Rudolph B, Rosenberger S, Biesen R, Kuhn A, et al. CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients. Arthritis Rheum. 2009;60(1):199\u2013206. https:\/\/doi.org\/10.1002\/art.24136.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"978_CR69","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1046\/j.1523-1755.2001.00045.x","volume":"60","author":"HB Richards","year":"2001","unstructured":"Richards HB, Satoh M, Jennette JC, Croker BP, Yoshida H, Reeves WH. Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane. Kidney Int. 2001;60(6):2173\u201380. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.00045.x.","journal-title":"Kidney Int"},{"issue":"7","key":"978_CR70","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.4049\/jimmunol.0802626","volume":"183","author":"OM Steinmetz","year":"2009","unstructured":"Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, et al. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis. J Immunol. 2009;183(7):4693\u2013704. https:\/\/doi.org\/10.4049\/jimmunol.0802626.","journal-title":"J Immunol"},{"issue":"5","key":"978_CR71","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.immuni.2012.10.010","volume":"37","author":"SK Lee","year":"2012","unstructured":"Lee SK, Silva DG, Martin JL, Pratama A, Hu X, Chang PP, et al. Interferon-\u03b3 excess leads to pathogenic accumulation of follicular helper T cells and germinal centers. Immunity. 2012;37(5):880\u201392. https:\/\/doi.org\/10.1016\/j.immuni.2012.10.010.","journal-title":"Immunity."},{"issue":"1","key":"978_CR72","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2017-000226","volume":"4","author":"MJ Boedigheimer","year":"2017","unstructured":"Boedigheimer MJ, Martin DA, Amoura Z, S\u00e1nchez-Guerrero J, Romero-Diaz J, Kivitz A, et al. Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-\u03b3 monoclonal antibody, in SLE subjects without or with lupus nephritis. Lupus Sci Med. 2017;4(1):e000226. https:\/\/doi.org\/10.1136\/lupus-2017-000226.","journal-title":"Lupus Sci Med"},{"issue":"10","key":"978_CR73","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1084\/jem.20051409","volume":"202","author":"Z Chen","year":"2005","unstructured":"Chen Z, Herman AE, Matos M, Mathis D, Benoist C. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J Exp Med. 2005;202(10):1387\u201397. https:\/\/doi.org\/10.1084\/jem.20051409.","journal-title":"J Exp Med"},{"issue":"9","key":"978_CR74","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood-2012-09-457465","volume":"121","author":"T Kinnunen","year":"2013","unstructured":"Kinnunen T, Chamberlain N, Morbach H, Choi J, Kim S, Craft J, et al. Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells. Blood. 2013;121(9):1595\u2013603. https:\/\/doi.org\/10.1182\/blood-2012-09-457465.","journal-title":"Blood."},{"issue":"5","key":"978_CR75","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133(5):775\u201387. https:\/\/doi.org\/10.1016\/j.cell.2008.05.009.","journal-title":"Cell."},{"issue":"3","key":"978_CR76","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.4049\/jimmunol.177.3.1451","volume":"177","author":"KJ Scalapino","year":"2006","unstructured":"Scalapino KJ, Tang Q, Bluestone JA, Bonyhadi ML, Daikh DI. Suppression of disease in New Zealand Black\/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol. 2006;177(3):1451\u20139. https:\/\/doi.org\/10.4049\/jimmunol.177.3.1451.","journal-title":"J Immunol"},{"issue":"1","key":"978_CR77","doi-asserted-by":"publisher","first-page":"R35","DOI":"10.1186\/ar4188","volume":"15","author":"O Weigert","year":"2013","unstructured":"Weigert O, von Spee C, Undeutsch R, Kloke L, Humrich JY, Riemekasten G. CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice. Arthritis Res Therapy. 2013;15(1):R35. https:\/\/doi.org\/10.1186\/ar4188.","journal-title":"Arthritis Res Therapy"},{"issue":"1","key":"978_CR78","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1073\/pnas.0903158107","volume":"107","author":"JY Humrich","year":"2010","unstructured":"Humrich JY, Morbach H, Undeutsch R, Enghard P, Rosenberger S, Weigert O, et al. Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus. Proc Natl Acad Sci U S A. 2010;107(1):204\u20139. https:\/\/doi.org\/10.1073\/pnas.0903158107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"978_CR79","doi-asserted-by":"publisher","first-page":"924","DOI":"10.4049\/jimmunol.1002218","volume":"186","author":"AA Divekar","year":"2011","unstructured":"Divekar AA, Dubey S, Gangalum PR, Singh RR. Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu. J Immunol. 2011;186(2):924\u201330. https:\/\/doi.org\/10.4049\/jimmunol.1002218.","journal-title":"J Immunol"},{"issue":"6","key":"978_CR80","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/art.23464","volume":"58","author":"V Parietti","year":"2008","unstructured":"Parietti V, Monneaux F, D\u00e9cossas M, Muller S. Function of CD4+,CD25+ Treg cells in MRL\/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells. Arthritis Rheum. 2008;58(6):1751\u201361. https:\/\/doi.org\/10.1002\/art.23464.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"978_CR81","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/intimm\/dxn044","volume":"20","author":"M Bonelli","year":"2008","unstructured":"Bonelli M, Savitskaya A, von Dalwigk K, Steiner CW, Aletaha D, Smolen JS, et al. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int Immunol. 2008;20(7):861\u20138. https:\/\/doi.org\/10.1093\/intimm\/dxn044.","journal-title":"Int Immunol"},{"issue":"4","key":"978_CR82","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.4049\/jimmunol.178.4.2579","volume":"178","author":"X Valencia","year":"2007","unstructured":"Valencia X, Yarboro C, Illei G, Lipsky PE. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol. 2007;178(4):2579\u201388. https:\/\/doi.org\/10.4049\/jimmunol.178.4.2579.","journal-title":"J Immunol"},{"issue":"4","key":"978_CR83","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/0961203307088307","volume":"17","author":"MI Vargas-Rojas","year":"2008","unstructured":"Vargas-Rojas MI, Crisp\u00edn JC, Richaud-Patin Y, Alcocer-Varela J. Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance. Lupus. 2008;17(4):289\u201394. https:\/\/doi.org\/10.1177\/0961203307088307.","journal-title":"Lupus."},{"issue":"7","key":"978_CR84","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/art.23556","volume":"58","author":"RK Venigalla","year":"2008","unstructured":"Venigalla RK, Tretter T, Krienke S, Max R, Eckstein V, Blank N, et al. Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -\/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum. 2008;58(7):2120\u201330. https:\/\/doi.org\/10.1002\/art.23556.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"978_CR85","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/cei.12991","volume":"189","author":"N Costa","year":"2017","unstructured":"Costa N, Marques O, Godinho SI, Carvalho C, Leal B, Figueiredo AM, et al. Two separate effects contribute to regulatory T cell defect in systemic lupus erythematosus patients and their unaffected relatives. Clin Exp Immunol. 2017;189(3):318\u201330. https:\/\/doi.org\/10.1111\/cei.12991.","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"978_CR86","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nm.4148","volume":"22","author":"J He","year":"2016","unstructured":"He J, Zhang X, Wei Y, Sun X, Chen Y, Deng J, et al. Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus. Nat Med. 2016;22(9):991\u20133. https:\/\/doi.org\/10.1038\/nm.4148.","journal-title":"Nat Med"},{"issue":"5","key":"978_CR87","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/ni.3390","volume":"17","author":"SA Apostolidis","year":"2016","unstructured":"Apostolidis SA, Rodr\u00edguez-Rodr\u00edguez N, Su\u00e1rez-Fueyo A, Dioufa N, Ozcan E, Crisp\u00edn JC, et al. Phosphatase PP2A is requisite for the function of regulatory T cells. Nat Immunol. 2016;17(5):556\u201364. https:\/\/doi.org\/10.1038\/ni.3390.","journal-title":"Nat Immunol"},{"issue":"12","key":"978_CR88","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/ni.3577","volume":"17","author":"VA Gerriets","year":"2016","unstructured":"Gerriets VA, Kishton RJ, Johnson MO, Cohen S, Siska PJ, Nichols AG, et al. Foxp3 and toll-like receptor signaling balance T(reg) cell anabolic metabolism for suppression. Nat Immunol. 2016;17(12):1459\u201366. https:\/\/doi.org\/10.1038\/ni.3577.","journal-title":"Nat Immunol"},{"issue":"274","key":"978_CR89","doi-asserted-by":"publisher","first-page":"274ra18","DOI":"10.1126\/scitranslmed.aaa0835","volume":"7","author":"Y Yin","year":"2015","unstructured":"Yin Y, Choi SC, Xu Z, Perry DJ, Seay H, Croker BP, et al. Normalization of CD4+ T cell metabolism reverses lupus. Sci Transl Med. 2015;7(274):274ra18. https:\/\/doi.org\/10.1126\/scitranslmed.aaa0835.","journal-title":"Sci Transl Med"},{"issue":"3","key":"978_CR90","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/art.40737","volume":"71","author":"M Dall'Era","year":"2019","unstructured":"Dall'Era M, Pauli ML, Remedios K, Taravati K, Sandova PM, Putnam AL, et al. Adoptive Treg cell therapy in a patient with systemic lupus erythematosus. Arthritis Rheumatol (Hoboken, NJ). 2019;71(3):431\u201340. https:\/\/doi.org\/10.1002\/art.40737.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-00978-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-020-00978-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-00978-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T17:16:48Z","timestamp":1697735808000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-020-00978-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["978"],"URL":"https:\/\/doi.org\/10.1007\/s11926-020-00978-5","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"assertion":[{"value":"8 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not involve human subjects or animal protocol necessary for ethics approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"12"}}